This meta-analysis emphasized the heterogeneity of PDL-1 expression across different sarcoma subtypes (primarily osteosarcomas, leiomyosarcomas, angiosarcomas, Ewing sarcomas, and non-specified STSs), suggesting that this variability might explain the inconsistent therapeutic outcomes observed in clinical settings. This evidence concerns the gene CD274 and osteosarcoma.